This is further supported by the prognostic value of a combined genetic signature of CD68, PDPN, and SEMA7A in predicting decreased distant metastasis free survival in a cohort of 600 human breast cancer cases[57]. This evidence concerns the gene SEMA7A and breast carcinoma.